These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24607437)

  • 21. Phosphodiesterase 10A PET radioligand development program: from pig to human.
    Plisson C; Weinzimmer D; Jakobsen S; Natesan S; Salinas C; Lin SF; Labaree D; Zheng MQ; Nabulsi N; Marques TR; Kapur S; Kawanishi E; Saijo T; Gunn RN; Carson RE; Rabiner EA
    J Nucl Med; 2014 Apr; 55(4):595-601. PubMed ID: 24614221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D
    Fazio P; Schain M; Mrzljak L; Amini N; Nag S; Al-Tawil N; Fitzer-Attas CJ; Bronzova J; Landwehrmeyer B; Sampaio C; Halldin C; Varrone A
    Neuroimage; 2017 May; 152():330-339. PubMed ID: 28254508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a novel PDE10A PET radioligand, [(11) C]T-773, in nonhuman primates: brain and whole body PET and brain autoradiography.
    Takano A; Stepanov V; Gulyás B; Nakao R; Amini N; Miura S; Kimura H; Taniguchi T; Halldin C
    Synapse; 2015 Jul; 69(7):345-55. PubMed ID: 25892433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.
    Niccolini F; Foltynie T; Reis Marques T; Muhlert N; Tziortzi AC; Searle GE; Natesan S; Kapur S; Rabiner EA; Gunn RN; Piccini P; Politis M
    Brain; 2015 Oct; 138(Pt 10):3003-15. PubMed ID: 26210536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of [¹¹C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors.
    Cox CD; Hostetler ED; Flores BA; Evelhoch JL; Fan H; Gantert L; Holahan M; Eng W; Joshi A; McGaughey G; Meng X; Purcell M; Raheem IT; Riffel K; Yan Y; Renger JJ; Smith SM; Coleman PJ
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4893-4898. PubMed ID: 26077491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vivo Evaluation of
    Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
    J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of binding and inhibitory properties of TAK-063, a novel phosphodiesterase 10A inhibitor.
    Harada A; Suzuki K; Kamiguchi N; Miyamoto M; Tohyama K; Nakashima K; Taniguchi T; Kimura H
    PLoS One; 2015; 10(3):e0122197. PubMed ID: 25815469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [
    de Laat B; Kling YE; Schroyen G; Ooms M; Hooker JM; Bormans G; Van Laere K; Ceccarini J
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):492-502. PubMed ID: 34142214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.
    Jin H; Zhang X; Yue X; Liu H; Li J; Yang H; Flores H; Su Y; Parsons SM; Perlmutter JS; Tu Z
    Nucl Med Biol; 2016 Feb; 43(2):131-9. PubMed ID: 26872437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate.
    Li J; Zhang X; Jin H; Fan J; Flores H; Perlmutter JS; Tu Z
    J Med Chem; 2015 Nov; 58(21):8584-600. PubMed ID: 26430878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
    J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography.
    Borroni E; Zhou Y; Ostrowitzki S; Alberati D; Kumar A; Hainzl D; Hartung T; Hilton J; Dannals RF; Wong DF
    Neuroimage; 2013 Jul; 75():291-300. PubMed ID: 22178811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphodiesterase 10A in Schizophrenia: A PET Study Using [(11)C]IMA107.
    Marques TR; Natesan S; Niccolini F; Politis M; Gunn RN; Searle GE; Howes O; Rabiner EA; Kapur S
    Am J Psychiatry; 2016 Jul; 173(7):714-21. PubMed ID: 26892941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis.
    Lin SF; Labaree D; Chen MK; Holden D; Gallezot JD; Kapinos M; Teng JK; Najafzadeh S; Plisson C; Rabiner EA; Gunn RN; Carson RE; Huang Y
    Synapse; 2015 Feb; 69(2):86-95. PubMed ID: 25450608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of [
    Liu H; Jin H; Yue X; Han J; Yang H; Flores H; Su Y; Alagille D; Perlmutter JS; Tamagnan G; Tu Z
    Pharmacol Res Perspect; 2016 Oct; 4(5):e00253. PubMed ID: 27713824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of Phosphodiesterase 10A (PDE10A) PET Tracer AMG 580 to Support Clinical Studies.
    Hu E; Chen N; Kunz RK; Hwang DR; Michelsen K; Davis C; Ma J; Shi J; Lester-Zeiner D; Hungate R; Treanor J; Chen H; Allen JR
    ACS Med Chem Lett; 2016 Jul; 7(7):719-23. PubMed ID: 27437084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [(11)C]T-773.
    Tóth M; Häggkvist J; Stepanov V; Takano A; Nakao R; Amini N; Miura S; Kimura H; Taniguchi T; Gulyás B; Halldin C
    Mol Imaging Biol; 2015 Aug; 17(4):445-9. PubMed ID: 25622810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [¹¹C]MP-10 PET rodent imaging study with ex vivo confirmation.
    Natesan S; Ashworth S; Nielsen J; Tang SP; Salinas C; Kealey S; Lauridsen JB; Stensbøl TB; Gunn RN; Rabiner EA; Kapur S
    Transl Psychiatry; 2014 Apr; 4(4):e376. PubMed ID: 24690597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [
    Svedberg MM; Varnäs K; Varrone A; Mitsios N; Mulder J; Gulyás B; Beaumont V; Munoz-Sanjuan I; Zaleska MM; Schmidt CJ; Halldin C; Mrzljak L
    Brain Res; 2019 May; 1711():140-145. PubMed ID: 30664847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.